News

Article

Pharmaceutical Technology

Pharmaceutical Technology-04-02-2004
Volume28
Issue 4

Synthetic Excipients Challenge All-Natural Organics

Author(s):

Ronelle Russell

Synthetic excipients frequently offer advantages over all-natural compounds.

External Link - article-91085.pdf

Articles in this issue
Spotlight on Business Risk
Vibration Technology for Active Dry-Powder Inhalers
In the Spotlight April 2004
FDA Attacks Counterfeits
Synthetic Excipients Challenge All-Natural Organics
April 2004

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com
August 23rd 2025

Johnson & Johnson Invests $2 Billion into North Carolina Facility

Susan Haigney
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 23rd 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results
August 23rd 2025

Bio/Pharma's Tariff Response: Key Insights from Industry Survey Results

Christopher Cole
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
August 23rd 2025

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com
August 23rd 2025

FDA Releases Guidance on Oncology Therapeutic Radiopharmaceuticals

Susan Haigney
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 23rd 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol